Tumor News and Research

RSS

Cellular sludge around hunger neurons linked to worsening diabetes and obesity

Investigating ECM changes in the hypothalamus reveals mechanisms behind insulin resistance, offering insights into obesity and metabolic disease treatment.

19 Sep 2024

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic lymphoma, a rare and slow-growing type of blood cancer, according to a study published recently in Nature Communications.

19 Sep 2024

Hypoxia's hidden role in boosting anti-cancer immunity

In the complex landscape of cancer, tumors create their own microenvironment, often marked by low oxygen levels, a condition known as hypoxia.

19 Sep 2024

Hemorrhages found to be more common in cancer patients than previously thought

In a recent study published in the scientific journal "Blood", researchers from MedUni Vienna show that hemorrhages are more common in cancer patients than previously thought and are associated with a poor prognosis and an increased risk of death.

18 Sep 2024

Lipid molecule fuels cancer growth

Cancer cells seldom start off stealthy. Quite to the contrary, they announce their presence to the immune system by planting chemical red flags right on their membranes. Once alerted, the body's defenses can swoop in, destroying rogue cells before they can do much damage. Lying at the heart of this early warning system are lipids, fatty compounds previously seen by cancer biologists primarily as a fuel source for burgeoning tumors.

18 Sep 2024

Study reveals higher breast cancer mortality risk for black women across all tumor types

Breast cancer is the most diagnosed cancer among U.S. women and the second leading cause of cancer death.

17 Sep 2024

Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.

17 Sep 2024

Ohio State's novel DHODH inhibitor enters first human trials

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.

17 Sep 2024

Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.

17 Sep 2024

Study finds immunotherapy effective for prostate cancer with certain DNA errors

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors.

16 Sep 2024

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a first-in-human study found 'promising' antitumor activity with a novel antibody drug conjugate (ADC) targeting the protein claudin 6 in heavily pretreated patients with ovarian and endometrial cancers.

16 Sep 2024

ESMO Congress 2024 to unveil future-focused cancer treatments

The ESMO Congress 2024 will hold a press conference to introduce and discuss the "Eyes to the Future" Presidential Symposium 3, that will be presenting prominent approaches that have the potential to become increasingly effective and influential components of cancer treatment in the (near) future.

16 Sep 2024

Novel delivery platform enhances effectiveness of cancer immunotherapy and reduces side effects

Immunotherapy is a type of cancer treatment that uses the body's own immune system to help fight cancer. This is by stimulating the immune response to recognize and attack cancer cells more effectively.

16 Sep 2024

Early data shows mRNA-4359 may benefit patients with advanced solid cancers

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers.

16 Sep 2024

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

14 Sep 2024

Key enzyme identified as potential target for cancer treatment

During every moment of any living organism's life, enzymes are at work. These crucial proteins support life through most biological processes, including metabolism, movement, respiration, and digestion.

14 Sep 2024

Scientists develop novel technique to combat T cell exhaustion

Fighting cancer is exhausting for T cells. Hostile tumor microenvironments can drain their mitochondrial activity, leading to a condition known as T cell exhaustion. This phenomenon also hinders adoptive cell therapies, in which healthy, tumor-targeting T cells are infused into patients with cancer. A novel method to boost mitochondrial activity and charge up T cells is needed.

14 Sep 2024

PPARs and PROTACs: A new strategy in cancer therapeutics

The growing challenge in cancer therapy lies in overcoming tumor heterogeneity, drug resistance, and associated side effects.

13 Sep 2024

Breakthrough study sheds light on mechanisms behind the spread of gastric cancer to the peritoneum

Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to 770,000 deaths each year.

13 Sep 2024

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in-class small molecule WRN inhibitor targeting advanced metastatic microsatellite instability (MSI) cancers guided by synthetic lethality strategy.

13 Sep 2024

Tumor News and Research

Cellular sludge around hunger neurons linked to worsening diabetes and obesity

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

Hypoxia's hidden role in boosting anti-cancer immunity

Hemorrhages found to be more common in cancer patients than previously thought

Lipid molecule fuels cancer growth

Study reveals higher breast cancer mortality risk for black women across all tumor types

Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

Ohio State's novel DHODH inhibitor enters first human trials

Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Study finds immunotherapy effective for prostate cancer with certain DNA errors

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

ESMO Congress 2024 to unveil future-focused cancer treatments

Novel delivery platform enhances effectiveness of cancer immunotherapy and reduces side effects

Early data shows mRNA-4359 may benefit patients with advanced solid cancers

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

Key enzyme identified as potential target for cancer treatment

Scientists develop novel technique to combat T cell exhaustion

PPARs and PROTACs: A new strategy in cancer therapeutics

Breakthrough study sheds light on mechanisms behind the spread of gastric cancer to the peritoneum

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News